Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL cohort

Journal of the American Geriatrics Society

Volumn 59, Issue 12, 2011, Pages 2201-2208

  Matheï, Catharina ^a,c   Vaes, Bert ^a   Wallemacq, Pierre ^b   Degryse, Jan ^a,c  

^a Institute of Health and Society   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

cytomegalovirus; elderly; frailty; functional impairment

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ACADEMIC ACHIEVEMENT; AGE; AGED; ARTICLE; BELGIUM; BODY MASS; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DAILY LIFE ACTIVITY; FEMALE; FRAIL ELDERLY; FUNCTIONAL DISEASE; GENERAL PRACTITIONER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PHYSICAL PERFORMANCE; PREVALENCE; PROTEIN BLOOD LEVEL; SERODIAGNOSIS; SEX; SMOKING;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; COGNITION DISORDERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FRAIL ELDERLY; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MALE; PROSPECTIVE STUDIES;

EID: 84055175593     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03719.x     Document Type: Article

References (39)

1. Ho M,. The history of cytomegalovirus and its diseases. Med Microbiol Immunol 2008; 197: 65-73.
2. Lubeck PR, Doerr HW, Rabenau HF,. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: What has changed? Med Microbiol Immunol 2010; 199: 53-60.
3. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al. Severe cytomegalovirus infection in apparently immunocompetent patients: A systematic review. Virol J 2008; 5: 47.
4. Slots J,. Herpesviral-bacterial synergy in the pathogenesis of human periodontitis. Curr Opin Infect Dis 2007; 20: 278-283. (Pubitemid 46686010)
5. Betjes MG, Litjens NH, Zietse R,. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant 2007; 22: 3298-3303. (Pubitemid 350202544)
6. Lawlor G, Moss AC,. Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander? Inflamm Bowel Dis 2010; 16: 1620-1627.
7. Ramos-Casals M, Cuadrado MJ, Alba P, et al. Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosus. Minerva Med 2009; 100: 437-446.
8. Sorlie PD, Nieto FJ, Adam E, et al. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2000; 160: 2027-2032. (Pubitemid 30437586)
9. Franceschi C, Bonafe M,. Centenarians as a model for healthy aging. Biochem Soc Trans 2003; 31: 457-461. (Pubitemid 36520700)
10. Pawelec G, Derhovanessian E, Larbi A, et al. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009 Jan; 19: 47-56.
11. Aiello AE, Haan M, Blythe L, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 2006; 54: 1046-1054. (Pubitemid 43992540)
12. Aiello AE, Haan MN, Pierce CM, et al. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci 2008; 63A: 610-618.
13. Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 2005; 53: 747-754. (Pubitemid 41656918)
14. Strandberg TE, Pitkala KH, Tilvis RS,. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009; 301: 380-382.
15. Wang GC, Kao WH, Murakami P, et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study. Am J Epidemiol 2010; 171: 1144-1152.
16. Roberts ET, Haan MN, Dowd JB, et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010; 172: 363-371.
17. Vaes B, Pasquet A, Wallemacq P, et al. The BELFRAIL (BFC80+) study: A population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr 2010; 10: 39.
18. Burgess C, Perry KR, Newham J, Kitchen A,. Evaluation of Abbott Architect CMV IgG assay NBSR07006. 2008. http://www.hpa-midas.org/reports
19. Guralnik JM, Winograd CH,. Physical performance measures in the assessment of older persons. Aging (Milano) 1994; 6: 303-305.
20. Penninx BW, Deeg DJ, van Eijk JT, et al. Changes in depression and physical decline in older adults: A longitudinal perspective. J Affect Disord 2000; 61: 1-12.
21. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49: M85-M94. (Pubitemid 24100267)
22. McWhinnie JR,. Disability assessment in population surveys: Results of the O.E.C.D. Common Development Effort. Rev Epidemiol Sante Publique 1981; 29: 413-419. (Pubitemid 12179806)
23. Stel VS, Smit JH, Pluijm SM, et al. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J Clin Epidemiol 2004; 57: 252-258. (Pubitemid 38456876)
24. De Craen AJ, Heeren TJ, Gussekloo J,. Accuracy of the 15-item Geriatric Depression Scale (GDS-15) in a community sample of the oldest old. Int J Geriatr Psychiatry 2003; 18: 63-66. (Pubitemid 36131228)
25. Tombaugh TN, McIntyre NJ,. The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 1992; 40: 922-935.
26. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56A: M146-M156. (Pubitemid 32187141)
27. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 1: 43.
28. Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and age-related diseases. Biogerontology 2010; 11: 547-563.
29. Leng SX, Xue QL, Tian, et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007; 55: 864-871. (Pubitemid 47011043)
30. Gress RE, Deeks SG,. Reduced thymus activity and infection prematurely age the immune system. J Clin Invest 2009; 119: 2884-2887.
31. Stassen FR, Vega-Cordova X, Vliegen I, et al. Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease? J Clin Virol 2006; 35: 349-353. (Pubitemid 43188987)
32. Stowe RP, Kozlova EV, Yetman DL, et al. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 2007; 42: 563-570. (Pubitemid 46756093)
33. Docke WD, Prosch S, Fietze E, et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343: 268-269. (Pubitemid 24039630)
34. Humar A, St Louis P, Mazzulli T, et al. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. J Infect Dis 1999; 179: 484-488. (Pubitemid 29086653)
35. Kuo CP, Wu CL, Ho HT, et al. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy. Clin Microbiol Infect 2008; 14: 221-227.
36. Ziemann M, Sedemund-Adib B, Reiland P, et al. Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008; 36: 3145-3150.
37. Strandberg TE, Pitkala KH, Linnavuori KH, et al. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 2003; 34: 2126-2131. (Pubitemid 37099824)
38. Derhovanessian E, Maier AB, Beck R, et al. Hallmark features of immunosenescence are absent in familial longevity. J Immunol 2010; 185: 4618-4624.
39. Leng SX, Qu T, Semba RD, et al. Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specific CD8 (+) T cells in older adults. Age (Dordr) 2011 [Epub ahead of print].